News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
The fourth article in Penn Today’s ‘Chapter of Change’ series highlights the evolution of life sciences innovation at Penn.
PCI staff served on panels to discuss technology transfer and commercialization.
Five teams developing opportunities across climate resilience, medical devices, sustainable materials, environmental monitoring, and diagnostics recently completed this program.
The program at uCity Square featured panel discussions on this key emerging area of Philadelphia’s economy.
In radiology, Penn researchers are using AI to support with more efficient medical imaging processes.
The special chewing gum is made from the lablab bean and is designed to neutralize disease-causing pathogens present in the mouth.
Researchers are developing a blood test to better predict the risk of kidney disease in Black Americans who carry high-risk APOL1 gene variants.
She leaves behind a lasting legacy in brain disease research, with discoveries that are drastically transforming the scientific understanding of diseases like Alzheimer's Disease and ALS.
They were recognized for developing groundbreaking ideas and businesses that transformed society.
Penn’s newest collaborative institution is the U.S. National Science Foundation Artificial Intelligence-driven RNA BioFoundry (NSF AIRFoundry), which uses AI to improve, accelerate, and scale the desi